# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹168.94 Cr** H1 FY26 (+1.17%) · **₹86.43 Cr** Q2 FY26 * EBITDA: ₹24.96 Cr H1 FY26 · ₹12.89 Cr Q2 FY26 (vs. ₹-73 Cr loss in Q1) * EBITDA Margin: 14.78% H1 FY26 · 14.91% Q2 FY26 · around 14.7% overall including other income * PAT: ₹8.71 Cr H1 FY26 (vs. ₹9.13 Cr prior) · ₹4.61 Cr Q2 FY26 (vs. ₹5.10 Cr prior) ## B. Revenue & Growth * **Divergent Trends:** Strong consolidated revenue growth despite sharp **de-growth in domestic revenues**, which fell QoQ across all segments including modeling and sleeving. * **Pricing Pressure:** Packaging product revenues stagnated despite **7% volume growth**, weighed down by a **67% price reduction**, while sheet sales declined by **₹10 Cr**. * **Management Outlook:** First half performance reflects seasonally strong quarters (Q1 and Q2), with **₹170 Cr** in revenue already achieved in H1 FY26, signaling robust execution. ## C. EBITDA & Margins * **Margin Volatility:** EBITDA swung to a small profit in Q2 after a significant Q1 loss, supported by **COGS improvement from 75% to 26%**, though pressured by higher fixed costs from Unit 3 ramp-up. * **Cost Inflation:** Employee costs rose **~15%** and job work expenses increased with higher Injection Moulding volumes, offsetting some margin gains. ## D. Cash Flow & Capex * **Self-Funded Expansion:** Odisha plant capex to be financed through **internal accruals**, with firm commitment to **avoid debt and equity dilution** (e.g., QIP) over the next two years. * **Contingency Flexibility:** While debt is currently ruled out, management acknowledged it may become necessary if capex needs exceed internal cash flow capacity. --- # 2. Volume & Pricing Trends ## A. Key Figures * **Volume Growth:** **7%** QoQ (+5–6% price degrowth from lower raw material/finished goods prices) * **EBITDA Margin (Injection Molding):** **~11%** (low capex, low depreciation & interest) * PBT Margin (Injection Molding): ~7–7.5% * **Target EBITDA Margin:** **16%** at **₹200 Cr** revenue ## B. Volume & Pricing Dynamics * **Volume Strength, Price Pressure:** Solid volume growth of 7% partially offset by **5–6% price degrowth**, driven by falling input and output prices. * **Cost Competitiveness Eroded:** Daman’s historical electricity cost advantage has **eroded due to market normalization**, removing a prior structural benefit. ## C. Margin Structure & Leverage * **Capital-Light Model Supports Margins:** Injection molding EBITDA margin holds at **~11%** due to **low depreciation and interest costs** from minimal capital expenditure. * **Path to Margin Expansion:** Management indicates a clear operating leverage trajectory, targeting a **16% EBITDA margin** at **₹200 Cr** revenue scale. * **Energy Cost Optimization Underway:** A **₹50 to ₹2 price delta** in energy costs is being actively addressed through efficiency initiatives. --- # 3. Segment & Product Performance ## A. Key Figures * Injection Moulding Revenue: ₹31.44 Cr H1 FY26 (+142%) · ₹18.58 Cr Q2 FY26 (+176%) * **Sheet Sales Revenue:** **₹36.29 Cr** H1 FY26 (↓ from ₹48.88 Cr) · **₹21.10 Cr** Q2 FY26 (↓ from ₹34.19 Cr) * **Olive Ecopak JV Revenue:** **₹19.86 Cr** H1 FY26 · **₹12.05 Cr** Q2 FY26 (↑ from ₹7.81 Cr Q1) * **Barrier Packaging Revenue:** **₹17 Cr** Q2 FY26 (~20% of thermoformed segment) * **JV Revenue Target:** **₹140–150 Cr** FY26–27 · **200–215 Cr** full-scale capacity * **JV EBITDA Margin Target:** **15–16%** expected FY27 ## B. Injection Moulding * **Explosive Growth Trajectory:** Injection moulding delivered strong double-digit growth with robust sequential momentum, driven by healthy domestic demand and scalable operations. * **Low-Capex, High-Return Expansion:** Segment is financially self-sustaining (PAT positive), with low capital intensity enabling viable capacity additions; expansion into IML planned post 1,200 MT scale-up. * **Strategic Product Evolution:** IML currently contributes **5% of revenues**, with phased expansion into higher-value categories prioritized after volume scale is achieved. ## C. Thermoformed Packaging * **Stable Core, Selective Growth:** Thermoformed packaging revenues held steady overall, but underlying volumes grew **7%**, excluding a large customer; barrier packaging now represents a meaningful **~20% share** of the segment. * **Growth Resilience:** Excluding one-time exposure, the segment demonstrates structural growth momentum supported by volume gains and product differentiation. ## D. Sheet Sales * **Sharp Revenue Decline:** Sheet sales collapsed year-on-year in both H1 and Q2, reflecting either demand softness or strategic de-emphasis, despite continued production of niche products like ultra-low temperature PP sheets. ## E. Olive Ecopak JV * **High-Volume Platform Scaling:** JV is among the country’s largest integrated producers with **7 crore units/day** installed capacity, now converting exhibition leads into sales traction. * **Ambitious Scale-Up Path:** Revenue is on track toward **₹140–150 Cr** in FY26–27, targeting full utilization by FY27–28, with **200+ Cr** peak revenue potential split between domestic and export markets. * **Margin Roadmap Defined:** JV expects **15–16% EBITDA margins** at targeted FY27 revenue levels, signaling improving profitability as scale ramps. --- # 4. Capacity & Utilization ## A. Key Figures * **Injection Moulding Capacity:** **4,800 MTPA** tolling basis (+1,500 MTPA) * **Olive Ecopak Capacity:** **27,000 MTPA** coating · **15,000 MTPA** packaging * **H1 Production:** **4,400 MT** (+~2,000 MT YoY) vs. prior capacity of ~3,500 MT ## B. Installed Capacity * **Strategic Geographic Layout:** Three core units—Unit 1 in Sarigam, Units 2 & 3 in Daman (25 mins apart); Olive Ecopak factory 15 mins from Sarigam. * **Scalable Infrastructure:** Recent expansion of **1,500 MTPA** in toll manufacturing supports export-led growth and domestic scaling. * **Near-Term Expansion Headroom:** **1,000–1,200 MTPA** additional capacity feasible within current footprint; further scale requires new land. ## C. Output Trends * **Production Growth Amid Constraints:** Strong YoY output increase in H1 despite persistent **mold change bottlenecks** and weather-impacted domestic demand. * **Thermoforming Output Stagnation:** Quarterly output range of **1,784–1,996 MT** since Q2FY23 reflects underutilization despite multi-year capacity additions. * **Declining Ancillary Output:** Printing and sleeving volumes show structural decline due to reduced thermoformed input, signaling product mix shift. ## D. Utilization Rates * **High Injection Moulding Utilization:** Toll-based operations achieving **~90%** utilization, indicating strong demand traction. * **Break-Even Target Set:** Domestic operations expected to reach **50% capacity utilization by Mar-26**, the threshold for PAT-level profitability. * **Focus on De-Risking:** Management prioritizing optimization of existing assets over new investments to improve cash flow and margins. ## E. Future Expansion * **Capex Pause for 12 Months:** Company deferring major investments to focus on **efficient capacity absorption** and financial performance. * **Odisha Greenfield Project on Hold:** Execution delayed **9–12 months** pending olive project progress; Phase I capex estimated at **₹25–35 Cr**. * **Renewables in Pipeline:** Exploring renewable power solutions to reduce energy costs, with potential announcement forthcoming. --- # 5. Export & Geography Mix ## A. Key Figures * Exports: ₹35.46 Cr in H1 FY26 (+79.66% YoY) · ₹22.05 Cr in Q2 FY26 (>100% YoY) ## B. Export Growth * **Robust International Demand:** Export surge driven by strong traction in the UK, Middle East, and U.S. markets, with **no supply chain disruption** despite a **50% tariff in the U.S.** * **Margin Advantage:** Export business delivers **slightly better margins** than domestic operations, enhancing profitability mix. * **Customer Retention:** Existing U.S. customers are absorbing higher tariffs, reflecting **pricing power and product stickiness**. ## C. Regional Distribution * **Diversified Export Base:** Exports span **13 countries**, with a balanced split—**40% from UK & Europe**, **40% from U.S.**, and **20% from Middle East**—reducing regional concentration. * **Emerging Markets:** Australia identified as a potential future market, though not yet targeted; expansion strategy focused on deepening current regional penetration. * **Domestic Channel Strength:** Domestic network includes **300+ customers**, including QSRs like **CCD**, and indirect reach via distributors to **Swiggy and Zepto DCs**, supporting scalable demand. ## D. Customer Expansion * **Global Brand Visibility:** Participation in marquee events—**Pack Expo Las Vegas, Anuga Anutec, Fine Food Australia**—generated strong international leads and market validation. * **Diverse End-Market Penetration:** Key consumption drivers include **food delivery, QSRs, airlines, large offices, and weddings**, with **paper disposables** gaining adoption across high-traffic segments. --- # 6. Demand & Customer Risks ## A. Key Figures * **Revenue Impact:** **₹8–10 Cr** in forgone revenue from packaging products due to customer off-take slowdown * **Customer Concentration:** Top 10 customers account for **~40%** of total revenue * **Tariff Impact:** **50%** tariff increase on US exports, fully absorbed by customers ## B. Key Customer Impact * **Beverage Segment Drag:** Declines in beverage thermoforming due to a major customer’s prolonged demand issues have weighed on sales and downstream printing/sleeving activity for over a year. * **Selective Customer Expansion:** Company is delaying new customer acquisition in key segments, opting to wait another quarter to assess market recovery before scaling further. * **Resilient Diversification:** Despite material disruption from a key customer in a seasonally strong segment, overall performance was stabilized by growth in non-beverage verticals. ## C. Monsoon Disruption * **Weather-Driven Softness:** Early and extended monsoon conditions suppressed domestic demand, particularly from institutional customers, limiting utilization of expanded capacities in H1. ## D. Tariff Challenges * **US Market Headwinds:** Export growth persists in injection moulding, but new customer acquisition in the US remains difficult due to tariffs, slowing Olive Eco pak adoption despite approvals. * **Diversified International Traction:** Positive momentum in Europe and the Middle East offsets US challenges, with growing interest from large domestic and international institutional buyers. * **Neutral GST Impact:** Recent GST reductions had negligible effect on demand, as end-product pricing in core categories remained largely unchanged. --- # 7. Guidance & Outlook ## A. Key Figures * **Q3 Revenue Guidance:** **₹16–18 Cr** (core business) (+33–50% vs. current run rate) · **₹22–24 Cr** projected for Q4 * **Annual Revenue Guidance:** **₹350 Cr** (core business only) (8–10% growth) vs. prior **₹365 Cr** (15–20%) * **Capacity-Based Revenue Potential:** **₹90–95 Cr** at 50% utilization (annualized) * **Implied H2 Revenue Target:** **~₹180 Cr** required in Q3 and Q4 to meet full-year guidance ## B. Revenue Forecast * **Downgraded Full-Year Outlook:** Revenue guidance revised down to **8–10% growth**, reflecting softer demand and delayed ramp-up, with core business excluding Olive Eco pack. * **Back-End Loaded Recovery:** Strong volume improvement expected in Q4, supported by new capacity (Unit 3) and customer business revival, driving sequential growth. * **Customer-Led Rebound:** Seasonal recovery anticipated from January–February, with a major customer’s strategic reset expected to boost utilization. ## C. Margin Expectations * **Margin Expansion Pathway:** EBITDA margins expected to reach **~16%** with **₹30–40 Cr** incremental revenue, driven by scale benefits and value-added product mix. * **Current Margin Pressure:** Margins remain subdued at **5%** against an initial 15% FY26 target, with no revised official guidance provided. ## D. Capacity Ramp-up * **Capex Delay on Tariff Watch:** Further capacity expansion delayed by one quarter to await potential **tariff reversals**, indicating cautious capital allocation. * **JV Nears Break-Even:** Joint venture on track to achieve break-even in Q4, with improved performance expected in FY27.